Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-02 Exercise | 2024-03-05 4:13 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Taylor Daphne SVP, CFO | 5,251 | $0 | 27,327 (Direct) | View |
2024-03-02 Exercise | 2024-03-05 4:12 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO | 9,167 | $0 | 52,171 (Direct) | View |
2024-03-02 Exercise | 2024-03-05 4:07 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kwon SoYoung SVP, GC, BD & Corp Affairs | 7,334 | $0 | 35,042 (Direct) | View |
2024-03-02 Exercise | 2024-03-05 4:06 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 22,501 | $0 | 102,847 (Direct) | View |
2024-01-29 Exercise | 2024-01-30 6:05 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Taylor Daphne SVP, CFO | 792 | $0 | 13,160 (Direct) | View |
2024-01-28 Exercise | 2024-01-30 6:04 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO | 1,833 | $0 | 28,337 (Direct) | View |
2024-01-28 Exercise | 2024-01-30 6:02 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 4,792 | $0 | 44,929 (Direct) | View |
2023-08-09 Exercise | 2023-08-10 4:12 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Niederhuber John Director | 3,571 | $0 | 5,682 (Direct) | View |
2023-08-09 Exercise | 2023-08-10 4:10 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kunz Barbara Lopez Director | 3,571 | $0 | 4,880 (Direct) | View |
2023-08-09 Exercise | 2023-08-10 4:08 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Harsanyi Zsolt Director | 3,571 | $0 | 8,475 (Direct) | View |
2023-08-09 Exercise | 2023-08-10 4:07 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Grant Grady III Director | 3,571 | $0 | 4,880 (Direct) | View |
2023-08-09 Exercise | 2023-08-10 4:05 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Abdun-Nabi Daniel Director | 3,571 | $0 | 8,339 (Direct) | View |
2023-08-08 Exercise | 2023-08-10 08:47 am | N/A N/A | Aptevo Therapeutics Inc. | APVO | Taylor Daphne SVP, CFO | 6,945 | $0 | 19,312 (Direct) | View |
2023-08-08 Exercise | 2023-08-10 08:44 am | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kwon SoYoung SVP, GC, BD & Corp Affairs | 9,375 | $0 | 26,083 (Direct) | View |
2023-08-08 Exercise | 2023-08-10 08:41 am | N/A N/A | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO | 13,812 | $0 | 42,150 (Direct) | View |
2023-06-01 Exercise | 2023-06-02 4:48 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Grant Grady III Director | 297 | $0 | 5,178 (Direct) | View |
2023-06-02 Option Award | 2023-06-02 4:48 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Grant Grady III Director | 3,571 | $0 | 5,178 (Direct) | View |
2023-06-01 Exercise | 2023-06-02 4:46 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kunz Barbara Lopez Director | 297 | $0 | 5,178 (Direct) | View |
2023-06-02 Option Award | 2023-06-02 4:46 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kunz Barbara Lopez Director | 3,571 | $0 | 5,178 (Direct) | View |
2023-06-01 Exercise | 2023-06-02 4:44 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Niederhuber John Director | 297 | $0 | 5,980 (Direct) | View |
2023-06-02 Option Award | 2023-06-02 4:44 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Niederhuber John Director | 3,571 | $0 | 5,980 (Direct) | View |
2023-06-01 Exercise | 2023-06-02 4:43 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Abdun-Nabi Daniel Director | 297 | $0 | 8,637 (Direct) | View |
2023-06-02 Option Award | 2023-06-02 4:43 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Abdun-Nabi Daniel Director | 3,571 | $0 | 8,637 (Direct) | View |
2023-06-01 Exercise | 2023-06-02 4:41 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Harsanyi Zsolt Director | 297 | $0 | 8,773 (Direct) | View |
2023-06-02 Option Award | 2023-06-02 4:41 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Harsanyi Zsolt Director | 3,571 | $0 | 8,773 (Direct) | View |
2023-05-31 Exercise | 2023-06-02 4:39 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kwon SoYoung SVP, GC, BD & Corp Affairs | 1,834 | $0 | 9,166 (Direct) | View |
2023-03-03 Exercise | 2023-03-07 4:44 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO | 3,666 | $0 | 53,026 (Direct) | View |
2023-03-03 Option Award | 2023-03-07 4:44 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO | 33,000 | $0 | 53,026 (Direct) | View |
2023-03-03 Exercise | 2023-03-07 4:42 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kwon SoYoung SVP, GC, BD & Corp Affairs | 3,666 | $0 | 34,833 (Direct) | View |
2023-03-03 Option Award | 2023-03-07 4:42 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kwon SoYoung SVP, GC, BD & Corp Affairs | 22,000 | $0 | 34,833 (Direct) | View |
2023-03-04 Exercise | 2023-03-07 4:41 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Taylor Daphne SVP, CFO | 1,583 | $0 | 30,590 (Direct) | View |
2023-03-03 Option Award | 2023-03-07 4:41 pm | N/A 2033-03-02 | Aptevo Therapeutics Inc. | APVO | Taylor Daphne SVP, CFO | 22,000 | $0 | 30,590 (Direct) | View |
2023-03-03 Exercise | 2023-03-07 4:37 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 9,582 | $0 | 136,805 (Direct) | View |
2023-03-03 Option Award | 2023-03-07 4:37 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 77,500 | $0 | 136,805 (Direct) | View |
Ownership | 2023-03-07 4:30 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Taylor Daphne SVP, CFO | 0 | $0 | 39,929 (Direct) | View |
2023-01-29 Exercise | 2023-01-30 1:07 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 4,791 | $0 | 35,347 (Direct) | View |
2023-01-29 Exercise | 2023-01-30 1:04 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. CFO | 1,834 | $0 | 10,859 (Direct) | View |
2022-08-09 Option Award | 2022-08-10 4:15 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Grant Grady III Director | 3,571 | $0 | 3,571 (Direct) | View |
2022-08-09 Option Award | 2022-08-10 4:14 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kwon SoYoung SVP, GC and Corporate Affairs | 18,750 | $0 | 18,750 (Direct) | View |
2022-08-09 Option Award | 2022-08-10 4:11 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kunz Barbara Lopez Director | 3,571 | $0 | 3,571 (Direct) | View |
2022-08-09 Option Award | 2022-08-10 4:09 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Abdun-Nabi Daniel Director | 3,571 | $0 | 3,571 (Direct) | View |
2022-08-09 Option Award | 2022-08-10 4:08 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. CFO | 34,958 | $0 | 34,958 (Direct) | View |
2022-08-09 Option Award | 2022-08-10 4:07 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Harsanyi Zsolt Director | 3,571 | $0 | 3,571 (Direct) | View |
2022-08-09 Option Award | 2022-08-10 4:06 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Niederhuber John Director | 3,571 | $0 | 3,571 (Direct) | View |
2022-06-07 Option Award | 2022-06-07 5:25 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. CFO | 11,000 | $0 | 11,000 (Direct) | View |
2022-06-07 Option Award | 2022-06-07 5:24 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kwon SoYoung SVP, GC and Corporate Affairs | 11,000 | $0 | 11,000 (Direct) | View |
2022-06-07 Option Award | 2022-06-07 5:23 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | White Marvin L President and CEO | 28,750 | $0 | 28,750 (Direct) | View |
2022-06-01 Exercise | 2022-06-03 3:16 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Abdun-Nabi Daniel Director | 298 | $0 | 8,703 (Direct) | View |
2022-06-01 Exercise | 2022-06-03 3:13 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | Kwon SoYoung SVP, GC and Corporate Affairs | 1,833 | $0 | 5,500 (Direct) | View |